[
  {
    "question_id": "patient-age",
    "question_text": "Patient Age",
    "answer": 45
  },
  {
    "question_id": "patient-gender",
    "question_text": "Patient Gender",
    "answer": "Female"
  },
  {
    "question_id": "current-bmi",
    "question_text": "Current BMI (kg/m²)",
    "answer": 32.5
  },
  {
    "question_id": "bmi-criteria",
    "question_text": "BMI meets criteria (≥30 kg/m² OR ≥27 kg/m² with weight-related comorbidity)?",
    "answer": true
  },
  {
    "question_id": "weight-related-comorbidities",
    "question_text": "Weight-related comorbidities (select all that apply)",
    "answer": ["Type 2 diabetes mellitus", "Hypertension"]
  },
  {
    "question_id": "baseline-weight",
    "question_text": "Baseline weight (kg) at treatment initiation",
    "answer": 95.5
  },
  {
    "question_id": "pregnancy-status",
    "question_text": "Is the patient pregnant or planning to become pregnant?",
    "answer": false
  },
  {
    "question_id": "breastfeeding-status",
    "question_text": "Is the patient currently breastfeeding?",
    "answer": false
  },
  {
    "question_id": "personal-medullary-thyroid-cancer",
    "question_text": "Personal history of medullary thyroid carcinoma (MTC)?",
    "answer": false
  },
  {
    "question_id": "family-medullary-thyroid-cancer",
    "question_text": "Family history of medullary thyroid carcinoma (MTC)?",
    "answer": false
  },
  {
    "question_id": "multiple-endocrine-neoplasia-syndrome",
    "question_text": "Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)?",
    "answer": false
  },
  {
    "question_id": "pancreatitis-history",
    "question_text": "History of pancreatitis?",
    "answer": false
  },
  {
    "question_id": "diabetic-retinopathy",
    "question_text": "History of diabetic retinopathy?",
    "answer": false
  },
  {
    "question_id": "gallbladder-disease",
    "question_text": "History of gallbladder disease?",
    "answer": false
  },
  {
    "question_id": "kidney-disease",
    "question_text": "Severe kidney disease or kidney failure?",
    "answer": false
  },
  {
    "question_id": "lifestyle-interventions",
    "question_text": "Has the patient attempted lifestyle interventions (diet and exercise) for at least 6 months?",
    "answer": true
  },
  {
    "question_id": "lifestyle-intervention-details",
    "question_text": "Describe lifestyle interventions attempted",
    "answer": "Patient participated in supervised diet program with nutritionist for 8 months and regular exercise program 3x/week. Lost 15 lbs initially but plateaued for past 4 months despite continued adherence."
  },
  {
    "question_id": "previous-weight-loss-medications",
    "question_text": "Previous weight loss medications tried (select all that apply)",
    "answer": ["Orlistat", "Phentermine/Topiramate"]
  },
  {
    "question_id": "previous-medication-response",
    "question_text": "Reason previous weight loss medications were discontinued",
    "answer": "Adverse effects/intolerance"
  },
  {
    "question_id": "prescriber-specialty",
    "question_text": "Prescriber Specialty",
    "answer": "Endocrinology"
  },
  {
    "question_id": "prescriber-name",
    "question_text": "Prescriber Name",
    "answer": "Dr. Sarah Johnson"
  },
  {
    "question_id": "prescriber-npi",
    "question_text": "Prescriber NPI",
    "answer": "1234567890"
  },
  {
    "question_id": "requested-dose",
    "question_text": "Requested Wegovy dose",
    "answer": "Semaglutide 0.25 mg/0.5 mL prefilled pen"
  },
  {
    "question_id": "duration-of-therapy",
    "question_text": "Requested duration of initial therapy authorization",
    "answer": "6 months"
  },
  {
    "question_id": "monitoring-plan",
    "question_text": "Monitoring plan during therapy",
    "answer": "Monthly visits for first 3 months to assess tolerance and side effects, then every 3 months. Labs including A1C, lipid panel, and kidney function every 6 months. Weight monitoring at each visit."
  },
  {
    "question_id": "recent-labs",
    "question_text": "Recent laboratory results available?",
    "answer": true
  },
  {
    "question_id": "consultation-notes",
    "question_text": "Nutrition/dietitian consultation notes available?",
    "answer": true
  },
  {
    "question_id": "additional-clinical-notes",
    "question_text": "Additional clinical notes or documentation",
    "answer": "Patient has documented weight loss attempts over past 2 years. Previous medications caused significant GI side effects. Patient motivated and understands injection requirements."
  },
  {
    "question_id": "medical-necessity",
    "question_text": "I attest that Wegovy is medically necessary for this patient and that the information provided is accurate and complete",
    "answer": true
  },
  {
    "question_id": "attestation-date",
    "question_text": "Date of attestation",
    "answer": "2025-09-13"
  }
]
